Today: 20 May 2026
TTM Technologies stock jumps as Raytheon’s $200 million deal and S&P MidCap 400 move stir buying
30 January 2026
1 min read

TTM Technologies stock jumps as Raytheon’s $200 million deal and S&P MidCap 400 move stir buying

New York, January 30, 2026, 14:04 EST — Regular session

  • TTMI climbed 3.7% in afternoon trading, bouncing between $95.06 and $103.36 earlier in the session
  • Company revealed a multi-year supply agreement with Raytheon, valued at up to $200 million
  • Investors are focused on the Feb. 4 results and the company’s 2026 outlook

TTM Technologies shares rose 3.7% to $100.03 Friday afternoon, bouncing back after an initial drop as investors reacted to new defense-contract news and picked up shares linked to index activity. The stock swung between $95.06 and $103.36, with roughly 1.8 million shares changing hands.

Timing is crucial. A multi-year defense contract provides suppliers steady work and clearer planning over extended programs. Shifts in the index can also trigger automatic buying, no matter what anyone thinks about the valuation.

The stock slips into a packed field of hardware and defense names, where any sign of slowing orders gets punished fast. With TTM’s quarterly update coming next week, traders see Friday’s rally more as a prelude than a finish line.

Late Wednesday, Costa Mesa-based TTM Technologies announced that Raytheon, part of RTX, secured a multi-year contract for radio frequency assemblies, electronic hardware, and printed circuit boards tied to the Lower Tier Air and Missile Defense Sensor radar program. The deal could be worth up to $200 million across three years. Mike Mills highlighted that the agreement supports “our accelerated delivery schedule while reducing costs.” Catherine Gridley of TTM described the move as one that “reinforces our long-standing partnership with Raytheon.” TTM Technologies, Inc.

Aside from the contract win, S&P Dow Jones Indices announced that TTM has been added to the S&P MidCap 400, effective before Friday’s open, moving out of the S&P SmallCap 600.

Index reshuffling like this often sparks quick, intense moves as passive funds realign their holdings. But these bursts usually subside fast, with the stock settling back into trading based on fundamentals.

Defense primes showed a mixed performance on Friday. RTX held steady, Lockheed Martin gained roughly 1%, and Northrop Grumman dropped close to 1.3%.

TTM is set to report its fourth-quarter 2025 earnings on Feb. 4, holding a conference call at 4:30 p.m. EST. The results will be released after the market closes.

However, the rally carries a distinct risk. That $200 million number is only “potential” value, with progress tied to program timelines and client demand; margins can shift even if revenue appears steady. A cautious note on Feb. 4 — or any hint of weakening orders — might reverse some of the gains from index moves and contracts.

Traders are focused on whether Friday’s gains stick through the close and carry over into next week’s positioning. The next major event is Feb. 4, when management will report results and provide guidance.

Stock Market Today

  • Euronext Q1 2026 Sees Record Trading Volumes and 15.3% Revenue Growth
    May 20, 2026, 5:43 AM EDT. Euronext reported a record Q1 2026 with cash equity trading and clearing revenue up 30.8% to €123 million, driven by high market volatility and the full contribution from Euronext Athens. Total underlying revenue rose 15.3% to €528.5 million, marking the exchange's eighth consecutive quarter of double-digit growth. Average daily cash equity transaction value in April reached €16.4 billion, with a 64.1% market share. Commodities trading revenue climbed 13.9%, while FX revenue grew 5.8%. ETF trading surged 84% since September 2025, boosted by the launch of mini ETF options. Adjusted EBITDA rose 16.7% to €343.2 million, with net income up 17.7%. Euronext declared a €3.18 dividend per share, reflecting a 50% payout, payable in May.

Latest articles

Co-Diagnostics Stock Surges — Then $3 Million Financing Puts The Rally To The Test

Co-Diagnostics Stock Surges — Then $3 Million Financing Puts The Rally To The Test

20 May 2026
New York, May 20, 2026, 05:08 EDT Co-Diagnostics shares face an early test on Wednesday after the diagnostic-test developer announced a $3 million private placement hours after its stock closed up 43.8% at $1.97 on Tuesday. Extended-hours trading showed the shares down 13.3% at $1.71 before the regular Nasdaq session. The timing matters. Co-Diagnostics had rallied after saying it had completed a strategy to develop an assay, or diagnostic test, for the Bundibugyo virus behind a fast-moving Ebola outbreak in Democratic Republic of Congo and Uganda. The late financing then shifted attention to dilution and cash needs. The company said
Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

20 May 2026
Micron Technology shares rose 2.5% Tuesday to $698.74, lifting its market value near $798 billion as the Nasdaq fell. Analysts cited tight memory supply and strong DRAM and NAND pricing. A planned strike by 48,000 Samsung workers Thursday could disrupt global memory supply, potentially raising prices. Micron recently sampled 256GB DDR5 server modules to partners.
Wall Street Puts $150 Target on Intel in AI Push

Wall Street Puts $150 Target on Intel in AI Push

20 May 2026
Intel shares rose 2.43% to $110.80 on Tuesday, ending a five-day losing streak. The stock rebounded as analysts raised price targets, citing demand for AI server CPUs. Intel traded between $102.40 and $113.07 during the session. The Nasdaq Composite fell 0.84%, with Nvidia and AMD also down.
Johnson & Johnson stock today: JNJ steadies after talc court win, EU panel backs AKEEGA expansion
Previous Story

Johnson & Johnson stock today: JNJ steadies after talc court win, EU panel backs AKEEGA expansion

Joby Aviation stock drops again as $1.2 billion capital raise puts dilution back in focus
Next Story

Joby Aviation stock drops again as $1.2 billion capital raise puts dilution back in focus

Go toTop